AstraZeneca PLC AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. ...
AstraZeneca Plc Share Company page Our story Webcasts Trade recap Fundamentals Analysis EquityWhat's this? Price (GBX)12,072.00 0.37% (44.00)AZNORD SHS $0.25 Track 6 more instruments Open / Last close11,968.00 / 12,072.00 High / Low12,072.00 / 11,914.00 ...
AstraZeneca PLC (AZN) $77.960.71(0.92%) Bid: 77.56 x 100Ask: 78.48 x 500 March 5, 2025 4:00 PMESTVolume: 4,910,520 After Hours: $77.960.00(0.00%)March 5, 2025 6:31 PMESTVolume: 442,089 USDNasdaq Global SelectDelayed PriceMarket Closed Earnings High Target Price 103.00 Mean Target...
AstraZeneca PLC (AZN) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
AstraZeneca PLC Price AstraZeneca PLC price|AstraZeneca PLC Quote Zacks Rank & Key Picks AstraZeneca carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the overall healthcare sector includeArcturus TherapeuticsARCT,BioventusBVSandFulcrum TherapeuticsFULC, each sporting a Zacks Rank #1 ...
Michel Demar� is a Belgian businessperson who has been at the helm of 6 different companies and presently holds the position of Chairman for AstraZeneca PLC and Chairman at Nomoko AG. He is also on the board of Vodafone Group Plc and Louis Dreyfus Company Holdings BV and Chairman...
Will AstraZeneca stock price hit 500 000 GBX price in a year? Not within a year. See above. Help us improve our free forecast service with share! Link to this Prediction: AstraZeneca PLC Forecast AstraZeneca (AZN) Forecast Earnings Growth AstraZeneca PLC (AZN) Stock Market info Recom...
Latest AstraZeneca PLC (AZNA:VIE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
1926:Imperial Chemical Industries (ICI, parent company of Zeneca PLC) founded in the UK. 1943:Astra develops Xylocane, which becomes the world's largest-selling local anesthetic. 1988:Hanakan Mogren appointed CEO of Astra AB. 1993:Zeneca PLC demerged from ICI. ...
The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release Imfinzi-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage...